Best Biliary Stricture Treatment Doctors in India

Dr. Murugan N

Dr. (Col) Avnish Seth

Dr. Sanjiv Saigal

Dr. Charles Panackel

Dr. Mallikarjun Sakpal

Dr. Narendra Singh Choudhary

Dr. Geeta Malkan Billa

What Patients with Biliary Stricture Worry About Most
A biliary stricture is a narrowing of the bile duct that blocks bile flow and causes jaundice, itching, and recurrent cholangitis. Patients worry about whether the stricture is cancer, whether stents will work, and whether surgery is needed. Many have already had jaundice, an endoscopic retrograde cholangiopancreatography with stenting, and a referral to a hepatobiliary unit. The honest position is that benign post-surgical strictures usually respond to endoscopic dilation and stenting in skilled hands. Malignant strictures need clear staging and a multidisciplinary plan. Either way, restoring bile flow is the priority.
How Biliary Stricture Is Diagnosed
Diagnosis starts with liver function tests showing a cholestatic pattern (raised alkaline phosphatase, gamma-glutamyl transferase, and bilirubin). Ultrasound shows bile duct dilation. Magnetic resonance cholangiopancreatography is the test of choice and maps the stricture, the length, and any associated mass. Endoscopic ultrasound with fine-needle aspiration helps when a mass is present, especially in distal common bile duct strictures. Cholangioscopy with targeted biopsy and confocal laser endomicroscopy is used in indeterminate cases. Computed tomography of the abdomen stages malignancy. Tumour markers (carbohydrate antigen 19-9, carcinoembryonic antigen) are checked.
Treatment Options for Biliary Stricture in India
Treatment depends on the cause. Benign post-surgical strictures (most often after laparoscopic cholecystectomy or liver transplantation) are first treated by endoscopic retrograde cholangiopancreatography with progressive balloon dilation and multiple plastic stents, or a single fully covered self-expandable metallic stent, exchanged every three months for around a year. Percutaneous transhepatic cholangiography is used when the endoscopic route fails. Surgical reconstruction with hepaticojejunostomy (Roux-en-Y) is offered when endoscopic therapy fails or for complete transections. Malignant strictures from cholangiocarcinoma or pancreatic head cancer are managed with endoscopic stenting and curative surgery if resectable, or palliative metal stenting with chemotherapy. Primary sclerosing cholangitis dominant strictures are managed with balloon dilation and short-term stenting. Institute of Liver and Biliary Sciences, Fortis Memorial Research Institute, Medanta, Apollo Hospitals, Asian Institute of Gastroenterology, and All India Institute of Medical Sciences run dedicated hepatobiliary programmes.
Recovery, Success Rates, and Follow-Up
Endoscopic management of benign post-surgical strictures has success rates around eighty to ninety percent with a one-year stenting programme. Surgical hepaticojejunostomy has long-term patency above ninety percent in experienced units. Endoscopic and percutaneous palliative stenting relieves jaundice in over ninety percent of malignant strictures. Hospital stay is one day for stent change, three to seven days for percutaneous transhepatic intervention, and seven to ten days for hepaticojejunostomy. Long-term follow-up includes liver function tests and imaging.
How to Choose the Right Hepatobiliary Unit for Biliary Stricture
Ask the unit about volumes of endoscopic retrograde cholangiopancreatography, percutaneous transhepatic cholangiography, and hepaticojejunostomy. Ask whether cholangioscopy, endoscopic ultrasound, and multidisciplinary hepatobiliary meetings are routine. Ask about the personalised plan for benign versus malignant strictures and the link with oncology if cancer is found.
International Patient Support
International patients receive a single coordinator who arranges magnetic resonance cholangiopancreatography, endoscopic retrograde cholangiopancreatography, percutaneous intervention, and surgery if needed. The Cancer Rounds team supports medical visa invitation letters, accommodation, airport transfers, and multilingual support in eleven plus languages. Patients arrive from Nigeria, Bangladesh, Kenya, Ethiopia, Iraq, Oman, and the United Arab Emirates for biliary stricture care. A written plan and cost estimate are shared before travel.
Frequently Asked Questions
How is a benign stricture different from a malignant one?
Benign strictures usually follow surgery, gallstones, or chronic inflammation and have a smooth, regular shape. Malignant strictures are abrupt and irregular, often with a mass on imaging. Cholangioscopy with biopsy and endoscopic ultrasound help when imaging is unclear.
How long do biliary stents stay in?
Plastic stents are exchanged every three months. Fully covered self-expandable metallic stents stay for six to twelve months in benign disease. Uncovered metallic stents in malignant disease typically last six to twelve months before re-intervention.
Is hepaticojejunostomy a permanent solution?
Hepaticojejunostomy has long-term patency above ninety percent in experienced units and is the gold standard for complete bile duct transection or failed endoscopic therapy. A small number need balloon dilation through a percutaneous route if anastomotic narrowing develops late.
What is cholangioscopy?
Cholangioscopy is a thin scope passed inside the bile duct through endoscopic retrograde cholangiopancreatography. It gives direct view of the stricture, allows targeted biopsy, and helps distinguish benign from malignant disease in indeterminate cases.
Why does a stricture cause itching?
Itching in biliary obstruction is from bile salts and bilirubin accumulating in the skin. Restoring bile flow with stenting or surgery resolves the itch in days. Anti-itch medications such as cholestyramine or rifampicin help while waiting for intervention.
Is endoscopic retrograde cholangiopancreatography risky?
Endoscopic retrograde cholangiopancreatography has small but real risks including pancreatitis, bleeding, perforation, and cholangitis. In high-volume units, the overall complication rate is around five percent. Most complications are mild and recover with conservative care.









